Notable Monday Option Activity: BLK, PCRX, PBI

Pacira BioSciences (PCRX) and Pitney Bowes (PBI) are experiencing significantly elevated options trading volumes today, with PCRX's options volume representing 67.6% and PBI's 66.7% of their respective average daily share trading volumes. This surge is notably concentrated in the July 2025 $25 strike call option for PCRX and the July 2025 $11 strike call option for PBI, indicating substantial speculative interest or long-term bullish positioning in both equities.

Analysis

Pacira BioSciences (PCRX) and Pitney Bowes (PBI) are exhibiting unusually high options market activity, indicating a significant shift in investor positioning. Today's options volume in PCRX represents 67.6% of its average daily share volume, while PBI's options volume accounts for 66.7% of its average. The activity is highly concentrated, suggesting targeted rather than broad-based speculation. For PCRX, a notable 1,803 contracts, representing over half the day's options volume, have traded on the July 18, 2025, $25 strike call. Similarly, PBI saw 8,514 contracts traded for its July 18, 2025, $11 strike call, also constituting more than half of its total options volume. The long-dated nature of these specific call options suggests that market participants are not merely trading short-term volatility but are potentially establishing longer-term bullish positions in anticipation of a significant appreciation in the underlying shares over the next year.

Key Decisions for Investors

• Investors should investigate potential undisclosed catalysts for both PCRX and PBI, as the concentrated, long-dated call buying suggests that some market participants may be positioning for a significant future development.
• Monitor the open interest and subsequent trading volumes in the PCRX July 2025 $25 calls and the PBI July 2025 $11 calls; sustained or increasing activity would strengthen the signal of bullish conviction.